Anti-leishmanial and structure-activity relationship of ring substituted 3-phenyl-1 -(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives

Memorias do Instituto Oswaldo Cruz

Volumn 103, Issue 8, 2008, Pages 778-780

  Burguete, Asunción ^a   Estevez, Yannick ^b,c   Castillo, Denis ^c   González, Germán ^c   Villar, Raquel ^a   Solano, Beatriz ^a   Vicente, Esther ^a   Silanes, Silvia Pérez ^a   Aldana, Ignacio ^a   Monge, Antonio ^a   Sauvain, Michel ^b   Deharo, Eric ^b  

^a Aplicada (CIFA)   (Spain)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

Anti leishmanial; Leishmaniasis; Quinoxaline; Structure activity

Indexed keywords

LEISHMANIA AMAZONENSIS; MURINAE;

EID: 58049166795     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762008000800006     Document Type: Article

References (16)

1. Burguete A, Pontiki E, Hadjipavlou-Litina D, Villar R, Vicente E, Solano B, Ancizu S, Pérez-Silanes S, Aldana I, Monge A 2007. Synthesis and anti-inflammatory/antioxidant activities of some new ring substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives and of their 4,5-dihydro-(1H)-pyrazole analogues. Bioorg Med Chem Lett 17: 6439-6443.
2. Davis AJ, Murray HW, Handman E 2004. Drugs against leishmaniasis: a synergy of technology and partnerships. Trends in Parasitol 20: 73-76.
3. Delorenzi JC, Attias M, Gattass CR, Andrade M, Rezende C, Pinto AC, Henriques AT, Bou-Habib DC, Saraiva E 2001. Antileishmanial activity of an indole alkaloid from Peschiera australis. Antimicrob Agents Chemother 45: 1349-1354.
4. Guillon J, Forfar I, Mamani-Matsuda M, Desplat V, Saliege M, Thiolat D, Massip S, Tabourier A, Leger JM, Dufaure B, Haumont G, Jarry C, Mossalayi D 2007. Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[l,2-a]quinoxalines as antileishmanial agents. Bioorg Med Chem 15: 194-210.
5. Marin A, Moreira Lima L, Solano B, Vicente E, Pérez Silanes S, Maurel S, Sauvain M, Aldana I, Monge A, Deharo E 2007. Antiplasmodial structure-activity relationship of 3-trifluoromethyl-2-arylcarbonylquinoxaline 1,4-di-N-oxide derivatives. Exp Parasitol 118: 25-31.
6. Monzote Fidalgo L, Montalvo Alvarez AM, Geigel LF, Pérez Pineiro R, Suárez Navarro M, Rodriguez Cabrera H 2004. Effect of thiadiazine derivatives on intracellular amastigotes of Leishmania amazonensis. Mem Inst Oswaldo Cruz 99: 329-330.
7. Rangisetty JB, Gupta CNVHB, Prasad AL, Srinivas P, Sridhar N, Parimoo P, Veeranjaneyulu A 2001. Synthesis of new arylaminoquinoxalines and their antimalarial activity in mice. J Pharm Pharmacol 53: 1409-1413.
8. Sauvain M, Dedet JP, Kunesch N, Poisson J, Gayral P, Gantier JC, Kunesch G 1993. In vitro and in vivo leishmanicidal activities of natural and synthethic quinoids. Phytother Res 7: 167-171.
9. Scherrer RA, Howard SM 1977. Use of distribution coefficients in quantitative structure-activity relationships. J Med Chem 20: 53-58.
10. Sereno D, Lemesre JL 1997a. Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents. Antimicrob Agents Chemother 41: 972-976.
11. Sereno D, Lemesre JL 1997b. Use of an enzymatic micromethod to quantity amastigotes stage of Leishmania amazonensis in vitro. Parasitol Res 83: 401-403.
12. Soto J, Toledo J, Valda L, Balderrama M, Rea I, Parra R, Ardiles J, Soto P, Gomez A, Molleda F, Fuentelsaz C, Anders G, Sindermann H, Engel J, Berman J 2007. Treatment of Bolivian mucosal leishmaniasis with miltefosine clinical infectious diseases. Clin Infect Dis 44: 350-356.
13. Valderrama JA, Zamorano C, González MF, Prina E, Fournet A 2005. Studies on quinones. Part 39: Synthesis and leishmanicidal activity of acylchloroquinones and hydroquinones. Bioorg Med Chem I: 4153-4159.
14. Valkó K 2004. Application of high-performance liquid chromatography based measurements of lipophilicity to model biological distribution. J Chromatogr 1037: 299-310.
15. Yardley V, Croft SL, de Doncker S, Dujardin JC, Koirala S, Rijal S, Miranda C, Llanos-Cuentas A, Chappuis F 2005. The sensitivity of clinical isolates of Leishmania from Peru and Nepal to miltefosine. Am J Trop Med Hyg 73: 272-275.
16. Zarranz B, Jaso A, Aldana I, Monge A, Maurel S, Deharo E, Jullian V, Sauvain M 2005. Synthesis and antimalarial activity of new 3-arylquinoxaline-2- carbonitrile derivatives. Arzncimittelforschung 55: 754-761.